SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Samrat Pharmachem submits a copy of Limited Review

25 Aug 2014 Evaluate

Samrat Pharmachem has submitted a Copy of the Limited Review Report for the period ended June 30, 2014.

The above information is a part of company’s filings submitted to BSE

Samrat Pharmachem Share Price

203.50 -15.40 (-7.04%)
24-Apr-2026 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1624.95
Dr. Reddys Lab 1317.90
Cipla 1287.20
Zydus Lifesciences 929.75
Lupin 2294.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×